Abstract Intraprotein electron transfer (IET) from flavin mononucleotide (FMN) to heme is essential in NO synthesis by NO synthase (NOS). Our previous laser flash photolysis studies provided a direct determination of the kinetics of the FMN-heme IET in a truncated two-domain construct (oxyFMN) of murine inducible NOS (iNOS), in which only the oxygenase and FMN domains along with the calmodulin (CaM) binding site are present (Feng et al. J. Am. Chem. Soc. 128, 3808-3811, 2006). Here we report the kinetics of the IET in a human iNOS oxyFMN construct, a human iNOS holoenzyme, and a murine iNOS holoenzyme, using CO photolysis in comparative studies on partially reduced NOS and a NOS oxygenase construct that lacks the FMN domain. The IET rate constants for the human and murine iNOS holoenzymes are 34 ± 5 and 35 ± 3 s -1 , respectively, thereby providing a direct measurement of this IET between the catalytically significant redox couples of FMN and heme in the iNOS holoenzyme. These values are approximately an order of magnitude smaller than that in the corresponding iNOS oxyFMN construct, suggesting that in the holoenzyme the rate-limiting step in the IET is the conversion of the shielded electron-accepting (input) state to a new electrondonating (output) state. The fact that there is no rapid IET component in the kinetic traces obtained with the iNOS holoenzyme implies that the enzyme remains mainly in the input state. The IET rate constant value for the iNOS holoenzyme is similar to that obtained for a CaM-bound neuronal NOS holoenzyme, suggesting that CaM activation effectively removes the inhibitory effect of the unique autoregulatory insert in neuronal NOS. 
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, respectively, thereby providing a direct measurement of this IET between the catalytically significant redox couples of FMN and heme in the iNOS holoenzyme. These values are approximately an order of magnitude smaller than that in the corresponding iNOS oxyFMN construct, suggesting that in the holoenzyme the rate-limiting step in the IET is the conversion of the shielded electron-accepting (input) state to a new electrondonating (output) state. The fact that there is no rapid IET component in the kinetic traces obtained with the iNOS holoenzyme implies that the enzyme remains mainly in the input state. The IET rate constant value for the iNOS holoenzyme is similar to that obtained for a CaM-bound neuronal NOS holoenzyme, suggesting that CaM activation effectively removes the inhibitory effect of the unique autoregulatory insert in neuronal NOS. Introduction NO, a ubiquitous cellular signaling molecule, is one of the most studied small molecules in biology owing to its involvement in numerous biological processes, such as vasodilation, neurotransmission, and immune response [1, 2] . There is still much that is unknown about how NO production by NO synthase (NOS) is tightly regulated [3] [4] [5] [6] [7] [8] [9] [10] . This is of biomedical importance because unregulated NO production by NOS has been implicated in an increasing number of diseases lacking effective treatments, including stroke, septic shock, and cancer [2, 11] . Mammalian NOS is a homodimeric flavohemoprotein that catalyzes the conversion of L-Arg to NO with NADPH and O 2 as cosubstrates [3, 12] . There are three mammalian NOS isoforms: endothelial NOS (eNOS), neuronal NOS (nNOS), and inducible NOS (iNOS). Each subunit of all three mammalian isoforms contains a C-terminal electronsupplying reductase unit with binding sites for NADPH (electron source), flavin adenine dinucleotide (FAD), and flavin mononucleotide (FMN), and an N-terminal catalytic heme-containing oxygenase domain. The FMN binding domain and the oxygenase domain are linked by a calmodulin (CaM) binding region. The substrate, L-Arg, and a cofactor, (6R)-5,6,7,8 tetrahydrobiopterin (H 4 B), both bind near the heme center in the oxygenase domain [6] .
Knowledge of the catalytic mechanism is incomplete [5, 6, 8, 9, 13, 14] , but it is well established that intraprotein electron transfer (IET) is important in NO synthesis through coupling reactions between the flavin and heme domains [4, 12, 15] . In particular, the IET from the FMN to heme is essential in the delivery of electrons required for O 2 activation in the heme domain and the subsequent NO synthesis by NOS, and is thus under extraordinary control. The kinetics of this IET process between the catalytically significant redox couples of FMN and heme is the focus of this study, and the results will be compared with those from our previous studies [16] [17] [18] [19] .
The eNOS and nNOS isoforms are signal generators that are tightly controlled by Ca 2? /CaM and other factors: CaM binding triggers the IET reaction from the FMN hydroquinone (FMNH 2 ) to the catalytic heme iron in the oxygenase domain of another subunit [20] . It is generally accepted that CaM binding has little effect on the thermodynamics of redox processes in NOS [21] [22] [23] , implying dynamic CaM regulation of IET via redox-linked conformational changes. iNOS, in contrast, synthesizes NO at all physiological Ca 2? concentrations. The major difference between the CaM-regulated isoforms of nNOS and eNOS and the Ca 2? -insensitive isoform iNOS is the presence of internal control elements [3] , such as a unique autoregulatory (AR) insert within the FMN domain [24] and the C-terminal tail [25] .
An ''FMN-domain tethered shuttle'' ( Fig. 1 ) was originally proposed by us [7] and is strongly supported by recent IET kinetic studies [16-19, 26, 27] , and involves the swinging of the FMN domain from its original electronaccepting (input) state to a new electron-donating (output) state; CaM binding unlocks the FMN domain from the input state, thereby enabling this domain to shuttle between the two states. Crystal structure study on an intact nNOS reductase domain in the CaM-free state [28] reveals the input state of FMN for electrons from NADPH through FAD (Fig. 1, top) , but not the output state. On the basis of the available structures of nNOS reductase [28] and oxygenase [29] constructs, FMN cannot be docked to within To favor observation of the output state of the shuttle mechanism, we designed truncated two-domain constructs (oxyFMN) of all three NOS isoforms, in which only the heme-containing oxygenase and FMN domains along with the CaM binding region are present, so as to enhance the interactions of the FMN binding domain with the oxygenase domain over interactions within the reductase unit [30] . The IET kinetics between the FMN and heme domains in the oxyFMN constructs of nNOS and iNOS demonstrated that the oxyFMN constructs are valid models of the NOS output state [18, 19] , and provide the first direct observation of CaM control of IET via facilitation of the FMN/heme interactions in the output state [18] . We have also further extended our CO photolysis approach to measure the IET kinetics in a rat nNOS holoenzyme [17] .
In the present work, we have investigated the kinetics of the IET between the FMN and heme domains in the murine and human iNOS holoenzymes. This allows us to address important open questions on the mechanism of the IET between the FMN and heme domains in NOS isoforms, and to extend and evaluate important ideas concerning the relationship between NO synthesis and electron transfer rates in mammalian NOS isoforms. Importantly, our results suggest that in the iNOS holoenzyme, the FMN domain shuttles between input and output states, and the protein exists primarily in the input state.
Materials and methods

Expression and purification of murine and human iNOS holoenzymes
The DNA-encoding murine and human iNOS holoenzyme was a kind gift from John Parkinson (Berlex Bioscience, USA), and was cloned in Escherichia coli expression vector pCWori? by reverse transcriptase PCR in the same way as described before [31] [32] [33] . iNOS was expressed in a protease-deficient E. coli strain BL21DE, and purified using a combination of ammonium sulfate precipitation, a nickel sulfate affinity column, and gel filtration chromatography, followed by 2 0 ,5 0 -ADP Sepharose column chromatography [32] . The iNOS activity was measured by spectrophotometric oxyhemoglobin assay [32] , and found to be between 1,100 and 1,300 nmol/min per milligram of protein. The purified iNOS holoenzyme contained between 0.8 and 1.0 heme per mole, and the flavin content measured after extraction from the protein was in all cases at least 90% of the heme content.
Cloning and protein purification of human iNOS oxyFMN
The human iNOS oxyFMN that carries a deletion of the first 70 amino acids and an N-terminal polyhistidine consists of residues 71-723 of the human iNOS enzyme. The construct was generated by PCR amplification of the human iNOS complementary DNA and the product was subcloned into pCWori?. The expression vector was coexpressed with wild-type CaM in E. coli BL21 (DE3), as in the previous studies [31, 34] . Purification of iNOS oxyFMN coexpressed with CaM proteins involved the removal of other proteins using a 30% ammonium sulfate cut followed by a 70% ammonium sulfate precipitation. The precipitated protein was resuspended in pellet buffer [40 mM tris(hydroxymethyl)aminomethane-HCl, pH 7.5, 1 mM L-Arg, 250 mM NaCl, 1 mM phenylmethylsulfonyl fluoride] and then purified using metal chelation chromatography. After the column had been washed with pellet buffer containing 50 mM imidazole, the protein was eluted using buffer containing 200 mM imidazole. The samples were dialyzed as previously described [35] , followed by the use of a Vivaspin 15 ultrafiltration spin column (Sartorius Biotechnology, Goettingen, Germany) to concentrate the protein. The FMN content of the protein was determined using the fluorescence method developed by Faeder and Siegel [36] . The FMN content of the purified human iNOS oxyFMN was greater than 93%.
Laser flash photolysis CO photolysis experiments were performed at room temperature, and the sample was kept in ice between flashes to stabilize the protein, as previously described [17] [18] [19] . Data from approximately 30 laser flashes were averaged, and transient absorbance changes were analyzed using the program SIFIT, obtained from OLIS (Jefferson, GA, USA). The laser apparatus and associated visible absorbance detection system have been extensively described [37] . Briefly, a N 2 laser (Photochemical Research Associates, London, ON, Canada) was used to pump a dye laser (450 nm wavelength maximum; Photochemical Research Associates), which was focused onto the sample cell, and used to trigger the reactions.
A solution containing 20 lM 5-deazariboflavin (dRF) and 5 mM fresh semicarbazide in pH 7.6 buffer [40 mM 1,3-bis[tris(hydroxymethyl)methylamino]propane (bis-Tris propane), 400 mM NaCl, 2 mM L-Arg, 20 lM H 4 B, 1 mM Ca 2? , and 10% glycerol] was well degassed in a laser photolysis cell by a mixture of Ar and CO (with a mole ratio of approximately 3:1). L-Arg was added to keep oxidized heme in a high-spin state. Aliquots of concentrated iNOS protein (150 lM) were subsequently injected through a septum, and the solution was kept in ice and further purged by passing the Ar/CO mixture over the surface for 40 min to remove minor oxygen before being subjected to illumination.
The iNOS solution was then illuminated for an appropriate period of time (approximately 90 s) to obtain a partially reduced form of [
• is flavin mononucleotide semiquinone), a process that was followed by characteristic absorptions of Fe(II)-CO and FMNH
• at 446 and 580 nm, respectively. The reduced protein was subsequently flashed with 450 nm laser excitation to dissociate CO from Fe(II)-CO, and generate a transient Fe(II) species that is able to intramolecularly transfer one electron to the FMNH
• to produce FMNH 2 and Fe 3? . This latter process was followed by the loss of absorbance of FMNH
• at 580 nm, and the loss of absorbance of Fe(II) at 465 and 430 nm. Since the reduced protein has a strong characteristic absorption of Fe(II)-CO at 450 nm relative to that of the FMN species, the energy of the 450 nm laser flash was predominately absorbed by Fe(II)-CO. The absorbance of dRF at this wavelength is nearly zero. As a control, solutions containing dRF alone in CO-degassed buffer were flashed with 450 nm laser excitation, and signals of much smaller magnitude were observed, as expected owing to the minimal absorption of dRF at 450 nm.
Results
Photochemical reduction of the oxidized murine and human iNOS holoenzymes by dRF semiquinone
The iNOS holoenzymes were partially reduced by illumination of the proteins in the presence of dRF. The basic photochemical process by which dRF semiquinone (dRFH • ) is generated and used as the exogenous reductant to reduce redox-active proteins has been extensively described [38, 39] . Since we observed similar photoreduction and IET kinetics for the murine and human iNOS holoenzymes, we have only reported here the results for murine iNOS holoenzyme in detail (see below).
The oxidized murine iNOS holoenzyme in the presence of dRF and CO was exposed to steady white light illumination for certain period of time to photoreduce the protein (Fig. 2a) . This steady-state difference spectrum has the characteristic peak of Fe(II)-CO at 446 nm and the broad band of flavin semiquinone around 580 nm. The UV-vis spectrum of the photoreduced iNOS also possesses the characteristic absorption band of oxidized flavin at 480 nm (Fig. 2b) , although with reduced intensity owing to reduction of flavins. Similar spectra were obtained for photoreduced nNOS holoenzyme in the presence of dRF and CO [17] . On the basis of the midpoint potentials of the FMN/FMNH
• and FAD/FADH
• couples in the iNOS holoenzyme (-105 and -240 mV, respectively) [22] , we assigned the absorption peaks to
, using the same published rationale [17] . Figure S1 shows the 450 nm laser flash induced difference spectra between 400 and 480 nm for the partially reduced iNOS holoenzyme (Fig. S1a) and iNOS oxygenase (iNOSoxy) construct containing no flavin cofactors (Fig. S1b) , respectively. The similarities in the absorption changes between these two NOS proteins indicate the prompt formation of free Fe(II). This is followed by a subsequent slow rebinding of CO to Fe(II) to regenerate the Fe(II)-CO complex. The rate constant of CO rebinding (1. ] form of the iNOS holoenzyme results in a decrease of the midpoint potential of the Fe(III)/Fe(II) couple to around -270 mV [22] , and thereby electron transfer from the transient CO-free Fe(II) (formed by the 450 nm laser) to FMNH
• may proceed. Figure S2 shows the 450 nm laser flash induced difference spectra between 530 and 600 nm for the photochemically reduced iNOS holoenzyme (Fig. S2a) and for the iNOSoxy construct (Fig. S2b) . Note the significant difference in the transient traces between 580 and 600 nm (highlighted in the dashed box in Fig. S2a ) between the iNOS holoenzyme and the iNOSoxy construct. The absorption of the iNOS holoenzyme at 580 nm rapidly decays below the baseline with a rate constant of 35 ± 3 s -1 (Fig. 3a) , followed by a slow recovery to the baseline at longer time with a rate constant of 1.1 ± 0.3 s -1 (Fig. 3b) , similar to that of the CO rebinding rate (1.8 ± 0.1 s -1 , see above). In other words, a ''transition,'' i.e., a reversal in direction of absorption changes over time, exists in the 580 nm trace for the iNOS holoenzyme (Fig. 3b) . In contrast, the 580 nm absorption of the iNOSoxy construct (which does not contain FMN) stays above the baseline (Fig. 3a, inset) . Note that FMNH
• dominates the absorption in the range of 580 nm [40] . More importantly, the rate constant of the absorption change at 580 nm for the iNOS holoenzyme is independent of signal amplitude (data not shown), indicating an intraprotein process. Our previous studies show that CO [19] , CaM-bound rat nNOS oxyFMN [18] , or CaM-bound rat nNOS holoenzyme [17] gives a similar decay followed by a slower CO rebinding at 580-600 nm. On the basis if these observations, we have assigned the rapid absorbance decay at 580 nm (Fig. 3a) to the following IET process between the catalytically significant redox couples of FMN and heme in the iNOS holoenzymes:
Because Fe(III)/Fe(II) and FMNH
• /FMNH 2 are nearly isopotential [22] , the electron transfer between Fe(II) and FMNH
• is reversible and the observed rate constant is the sum of the forward (k f ) and reverse (k r ) electron transfer steps. Since the FMN-heme IET reaction is an equilibrium process, we are in fact measuring it in both directions; however, the CO photolysis technique follows the IET process in the reverse direction of the enzymatic turnover. Thus, both k r (i.e., heme reduction) and k f in the murine iNOS holoenzyme at pH 7.6 are approximately 18 ± 2 s -1 . The observed IET rate constants are listed in Table 1 . Previous stopped-flow studies on heme reduction in the iNOS holoenzyme gave rate constants of 0.9-1.5 s -1 [41] ; these experiments were conducted at 10°C. Note that our experiments were at room temperature; the difference between the reported rate constants might be due to different temperatures, which could cause the reported slower rates in the stopped-flow experiments. The ''transition'' feature in the 580 nm trace (Fig. 3b ) also exists in the kinetic traces at 465 and 430 nm for the murine iNOS holoenzyme (Fig. 4b) ; however, such a ''transition'' was absent in the 465 nm/430 nm traces for the iNOSoxy construct (data not shown). Moreover, this transition feature does not clearly exist in other traces between 410 and 480 nm (Fig. S3) . The rapid decay in the 465 and 430 nm traces can be well fitted by a single-exponential model, giving rate constants of 36 ± 2 and 34 ± 1 s -1 , respectively (Fig. 4a) , which are similar to the value obtained from the 580 nm trace (35 ± 3 s -1 , Fig. 3a) . The subsequent slow recovery at 465 and 430 nm (Fig. 4b ) also gave a rate constant (0.9 ± 0.4 and 0.8 ± 0.4 s -1 , respectively), comparable to that for the CO rebinding process (1.8 ± 0.1 s -1 ). These results strongly indicate that the rapid decay in the 465 and 430 nm traces (Fig. 4a) is also due to the IET between the FMN and heme domains (Eq. 1).
Upon CO dissociation by photolysis of the [Fe(II)-CO][FMNH •
], three processes take place after the 450 nm laser flash, and these may contribute to the absorption changes at 465 and 430 nm:
Because the rate constant for the decay (approximately 35 s -1 ) was much faster than that of the CO rebinding (1.8 s -1 ) and, more importantly, a transition exists in the traces (Fig. 4b) , the rapid decay cannot be due to the process in Eq. 2, i.e., the CO rebinding process.
Note also that the amplitudes of the 430 and 465 nm trace were approximately 3 times and approximately 2 times that of the 580 nm trace for the same sample, respectively (Fig. S4) . It is very unlikely for the process in Eq. 4 to give rise to the rapid decay at 465 nm/430 nm, because the absorbance change due to this reaction (i.e., the FMNH
• /reduction transition) is approximately isosbestic at , and 10% glycerol, pH 7.6. About 20 lM 5-deazariboflavin solutions with 5 mM fresh semicarbazide in the buffer were used. A mixture of CO/Ar (1:3) was used to degas the 5-deazariboflavin solution and purge the concentrated iNOS. k et obs values for murine and human iNOS two-domain NO synthase constructs in which only heme-containing oxygenase and FMN domains along with the CaM binding site are present are 850 ± 50 s -1 [19] and 320 ± 45 s -1 (this study), respectively a Experiments were repeated with 4.6 and 7.4 lM murine iNOS b Experiments were repeated twice at 11 lM human iNOS (Fig. 3b) . Experimental conditions were the same as Fig. 3 430 nm, and maximal around 580 nm, with an intermediate amplitude at 465 nm [42] . This leaves the process in Eq. 3 as most likely responsible for the rapid decay at 430 nm/ 465 nm.
Indeed, given the facts that (1) heme reduction in iNOSoxy gives positive absorption changes at 430 nm/ 465 nm (Fig. S5) and (2) 430 and 465 nm are isosbestic points in the flash-induced difference spectra of the [Fe(II)-CO] form of iNOSoxy (Fig. S6) , we assigned the rapid decay at 430 nm/465 nm (Fig. 4a) to the heme oxidation process, i.e., the process in Eq. 3, in the FMN-heme IET (Eq. 1). The larger amplitude of the 430 nm/465 nm trace (compared with that of the 580 nm trace, Figs. 3a, 4a ) is due to much larger absorption coefficients of the heme species than the flavin species in NOS. Therefore, we can follow the IET kinetics in the murine iNOS holoenzyme either by net reduction of FMNH
• at 580 nm, or by net oxidation of heme at 430 nm/465 nm. At other wavelengths, the Fe(II)-CO and Fe(II) species dominate the absorption, thus masking observation of the heme oxidation (the process in Eq. 3) (Fig. S3) .
A similar trace with a ''transition'' at 460 nm, rather than at 465 nm, was also observed for the CaM-bound nNOS holoenzyme [16] . In agreement with the rationale described above for iNOS, the isosbestic point of CO rebinding in the nNOS oxygenase construct is around 460 nm, rather than at 465 nm. These results with nNOS further validate our assignment of the rapid decay in the 465 nm trace to the FMN-heme IET in iNOS. The isosbestic point for the CO rebinding process gives only a narrow spectral window at these wavelengths to observe the heme oxidation in the full-length NOS proteins. At other wavelengths, the heme oxidation signal is overlapped by the contributions from the CO rebinding process, which gives much larger absorbance changes. ] form results in a rapid decay at 580 nm below the preflash baseline with rate constant of 320 ± 45 s -1 (Fig. 5a ), followed by a slow recovery to the baseline at longer time with a rate constant of 1.1 ± 0.1 s -1 (Fig. 5b) , similar to that of the CO rebinding rate constant (1.5 ± 0.2 s -1 ) obtained from the traces at 455 nm, where Fe(II) and Fe(II)-CO species dominate the absorption. The rate constant of the rapid decay at 580 nm for the human iNOS oxyFMN construct is independent of signal amplitude (data not shown), indicating an intraprotein process. The transition feature in the traces at 580 nm also clearly exists in the traces at 430 and 465 nm (data not shown), as was the case for the murine and human iNOS holoenzymes (see before).
Discussion
The kinetics reported here for the IET in the iNOS holoenzymes (Table 1) are about an order of magnitude slower than the kinetics in the corresponding iNOS oxyFMN constructs [19] . Measurement of the IET in the nNOS holoenzyme gave a rate constant of 36 s -1 , also roughly an order of magnitude smaller than the value obtained in experiments with the nNOS oxyFMN construct [17] . Note that the truncated oxyFMN constructs, in which only the heme-containing oxygenase domain and the FMN domain, along with the CaM binding region, are present, are designed to remove the constraints from the NADPH-FADbinding domain [30] . The IET reaction scheme in the holoenzyme can be represented as follows:
where sq represents ''semiquinone'', hq represents ''hydroquinone'', red represents ''reduced'', and ox represents ''oxidized''. The fact that the IET rate constant in the holoenzyme is approximately an order of magnitude smaller than that in the corresponding oxyFMN construct suggests that in the holoenzyme the rate-limiting step in the IET is the conversion of the input state to the output state (i.e., the first step in the above scheme, in which the FMN becomes accessible to the heme), and that the role of CaM is to allow this conversion to occur (Fig. 1) . Note that in the iNOS oxyFMN and nNOS oxyFMN (with added CaM) constructs, the IET rate constants are much larger and not equal in the oxyFMN constructs, although they are of similar order of magnitude (850 ± 50, 320 ± 45, and 262 ± 40 s -1 , for oxyFMN constructs of murine iNOS [19] , human iNOS, and rat nNOS [17] , respectively). Therefore, the limiting factor in the nNOS and iNOS holoenzyme is not the FMN-heme IET per se. As a preliminary interpretation, we propose that at least some of the interactions that constrain the holoenzyme to be in the input state are lost in these oxyFMN constructs, making it easier for the truncated protein to achieve the output state, thereby increasing the IET rate constant. Structural studies will be required to better understand this difference.
The fact that there is no rapid IET component in the traces obtained with the iNOS holoenzyme (Figs. 3a, 4a ) implies that the holoenzyme is mainly in the input state, despite having CaM bound to it; the iNOS holoenzyme is still constrained by the contacts that exist which control the rate constant for the IET. If there were a mixture of input and output states when the reaction was initiated by the laser flash, the decay would be biphasic, with rate constants and amplitudes determined by the characteristics of the two states; only the enzyme fraction initially in the ''input state'' should display slow apparent IET, while enzyme already in the ''output state'' should show the same rapid IET kinetics that was reported for the oxyFMN constructs.
CaM unlocks the input state, thereby enabling the FMN domain to shuttle between the two enzyme states, and thus make contacts with the heme domain (Fig. 1) ; the CaM effect is primarily kinetic, although there may be a thermodynamic component as well [43] . CaM does not affect the kinetics of the rate-limiting step (i.e., conversion of the input state to the output state, see above); the evidence for this is that the IET rate constant for the holoenzyme is smaller than that for the oxyFMN construct. Thus, in the holoenzyme, the IET rate constant is still controlled by the conversion step, even when CaM is present. The IET in the oxyFMN construct is faster because it has lost contacts with the FAD domain that constrain this motion.
The experiments reported here show that in the iNOS holoenzyme the rate constant for the IET between heme and FMN is indistinguishable from our previously reported rate for CaM-activated nNOS holoenzyme [17] . This is a remarkable observation considering that in nNOS holoenzyme the IET in the absence of CaM is too slow to measure , and 10% glycerol). Note the significant difference in the time scale of a and Fig. 3a [17]. Control of the IET processes in eNOS/nNOS by CaM has been shown to mainly involve the CaM binding site [44] , and the unique AR insert within the FMN binding domain [24, 45] . The AR insert within the FMN domain, in the absence of CaM, locks the FMN binding domain to the reductase complex via a network of hydrogen bonds so as to obstruct CaM binding and enzyme activation [28] . It is proposed that when CaM binds to the linker between the FMN and oxygenase domains at high Ca 2? concentration, the AR insert is displaced so that the enzyme can be activated. Indeed, our results suggest that in nNOS holoenzyme CaM activation effectively removes the restraints imposed by the nNOS unique AR insert on the release of the FMN binding domain, at least in single turnover. Importantly, our recent study on an nNOS AR-deletion mutant demonstrated that the rate-limiting conversion of the input state to a new output state does not involve interactions with the AR insert [16] . Although the results presented here and those in the previous study [16] support each other, the AR-deletion mutant is an artificial construct, whereas the iNOS holoenzyme is a native form.
Santolini et al. [41, 45] have proposed a ''global model'' for NOS catalysis including feedback inhibition by geminate NO produced in the catalytic cycle. In this model nNOS is approximately 80% inhibited in the steady state, while iNOS is much less inhibited (approximately 15%) because of the more rapid reaction of oxygen with the ferrous NO complex; eNOS is essentially uninhibited because of much slower rates of heme reduction. Note that the bulk of the data used in their modeling were obtained at 10°C. Some of the details of our observations differ from the parameters used in their modeling; in particular, they assert that the rate of ferriheme reduction in nNOS is more rapid than in iNOS (at 10°C) [41, 46] , while results presented here and in our previous paper [17] show that these rates are indistinguishable (at 25°C). If the steady-state rates of NO synthesis by iNOS and nNOS were determined purely by the rate of reduction of ferriheme, our IET results would suggest that these NO synthesis rates would be equal. However, the steady-state rate of NO synthesis by iNOS at 25°C is two-to three-fold faster than the rate of NO synthesis by nNOS (D.K. Ghosh, unpublished results). The global model is needed to account for the difference in NO synthesis rates: if the proportions of iNOS and nNOS in the inhibitory ferrous NO complex at 25°C were the same as at 10°C, the global model would predict that steady-state NO production of iNOS would be 3-4 times greater than that of nNOS. Therefore, overall our results offer strong support for the basic ''global model'' (at 10°C), and extend it to higher temperatures (25°C).
Two factors may complicate this assessment, however. On one hand, the degree of NO inhibition of both enzymes is likely to vary with temperature since it is determined by the interaction of several temperature-dependent rate constants. In addition, the steady-state rate of reduction of ferriheme is unlikely to correspond exactly to the singleturnover rate we measure. More precisely, the steady-state rate of heme reduction will be determined by the interaction of multiple processes in the catalytic cycle of the reductase unit. The single-turnover IET rates measured in our experiments represent important features of this cycle and provide upper limits of the steady-state rates, but assessment of the steady-state rates requires in addition partitioning of the system (e.g., by King-Altman kinetics). Understanding the kinetics and control of NOS will require an assessment of the interaction of kinetics models of the oxygenase unit with kinetics models of the reductase unit. We intend to present more detailed assessments, including King-Altman modeling of the reductase unit, in subsequent communications.
It is interesting that the reduction of oxygenase heme and that of cytochrome c both require release of the FMN domain from the input state, but that V max for cytochrome c reduction in all mammalian isoforms [25] is an order of magnitude faster than the reduction of heme reported in this work. For cytochrome c reduction we can postulate a reaction first order in ferric cytochrome c and in accessible FMN binding domains; the rate of formation of the complex with cytochrome c is then the second-order rate constant k cf (cytochrome c complex formation) times the concentration of enzyme molecules with accessible FMN binding domains. The rapid rate of cytochrome c reduction could be accounted for by a large value of k cf , but it is more informative to consider the ''free'' FMN binding domain as partitioning into a range of conformational states. If a much larger number of these states are accessible to cytochrome c than to the oxygenase domain, we would expect much more rapid reduction of cytochrome c under saturated cytochrome c concentration. This is a reasonable expectation given the small size of cytochrome c and the conformational constraints placed on the oxygenase/FMN complex by the dimeric structure of NOS and the connecting polypeptides linking the domains.
In ] form of iNOS holoenzyme has allowed us to directly observe the discrete IET step between the catalytically significant redox couples of FMN and heme in the holoenzyme. This work suggests that the FMN domain in the iNOS holoenzyme shuttles between a shielded electronaccepting (input) state and an electron-donating (output) state, and the enzyme remains mainly in the input state. The rate constants are remarkably similar to those obtained in studies of the CaM-bound nNOS holoenzyme. These results demonstrate that the basic control mechanisms acting in these NOS homologs are similar, and that CaM activation appears to effectively remove the inhibitory effect of the unique AR insert in nNOS.
